Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Total 13F shares
-
4,205,096
-
Share change
-
+2,049,273
-
Total reported value
-
$51,006,563
-
Price per share
-
$12.12
-
Number of holders
-
46
-
Value change
-
+$24,949,309
-
Number of buys
-
39
-
Number of sells
-
6
Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q2 2020
As of 30 Jun 2020 IMMUNIC, INC. - Common Stock (IMUX) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,205,096 shares of stock of the company.
Largest 10 holders included Omega Fund Management, LLC, Artal Group S.A., VANGUARD GROUP INC, BlackRock Inc., Granite Point Capital Management, L.P., Point72 Asset Management, L.P., CVI Holdings, LLC, RENAISSANCE TECHNOLOGIES LLC, Parkman Healthcare Partners LLC, and FMR LLC.
This table shows 46 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.